Patent 7273624 was granted and assigned to Abbott on September, 2007 by the United States Patent and Trademark Office.
The invention relates to stable solid dosage forms for peroral administration containing, in addition to an ubiquinone, at least one thermoplastically processible matrix-forming auxiliary agent.